Recent publications · Crossref
5 total works indexed
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
· 2019 · cited 2,530x
- TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
· 2024 · cited 2,017x
- The Future of Peptide‐based Drugs
· 2012 · cited 1,777x
- Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
· 2014 · cited 1,414x